Form 4: DocGo Inc. Executive Stephen Sugrue Reports Stock Transactions Following RSU Vesting
SEC Form 4 Filing
Stephen Sugrue, Chief Compliance Officer of DocGo Inc., reports acquisition and disposal of common stock related to the vesting of performance-based restricted stock units (RSUs).
Summary
- On March 7, 2025, Stephen Sugrue, Chief Compliance Officer of DocGo Inc., reported transactions involving DocGo Inc. common stock.
- These transactions are related to the vesting of performance-based restricted stock units (RSUs) granted on December 12, 2023, under the company's 2021 Stock Incentive Plan.
- Mr. Sugrue acquired 77,520 shares of common stock upon the vesting of these RSUs.
- Simultaneously, 7,789 shares were withheld to cover Mr. Sugrue's tax liability at a price of $3.03 per share.
- Following these transactions, Mr. Sugrue beneficially owns 352,942 shares of DocGo Inc. common stock, including additional RSUs that will vest in the future.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.
Future Outlook
The remaining performance-based RSUs will vest in three equal annual installments on the second, third, and fourth anniversaries of the grant date, subject to the terms of the Plan; additional RSUs will vest according to their respective schedules.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the trading activities of company executives.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in corporate governance, and Form 4 filings are a standard requirement across publicly traded companies.
- Companies like Teladoc Health and Amwell, which also operate in the telehealth space, have similar reporting requirements for their executives' stock transactions.
- The vesting schedules and equity compensation plans are generally comparable to industry norms for executive compensation.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
- Employees may be interested in the details of the company's stock incentive plan.
Key Dates
| Date | Description |
|---|---|
| December 12, 2023 | Grant date of performance-based restricted stock units (RSUs). |
| March 7, 2025 | Certification date of performance criteria for RSUs and transaction date for stock acquisition and disposal. |
| March 11, 2025 | Date of signature on the Form 4 filing. |
| April 1, 2025 | Date of one of the vesting installments for 22,770 RSUs. |
| July 1, 2025 | Date of one of the vesting installments for 22,770 RSUs. |
| December 12, 2025 | Date of one of the vesting installments for 72,674 RSUs. |
| December 12, 2026 | Date of one of the vesting installments for 72,674 RSUs. |
| December 12, 2027 | Date of one of the vesting installments for 72,674 RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.